Ebola virus disease: What clinicians in the United States need to know

American Journal of Infection Control

Volumn 43, Issue 8, 2015, Pages 788-793

  Fischer, William A ^a   Uyeki, Timothy M ^b   Tauxe, Robert V ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Person under investigation; Personal protection equipment; Viral hemorrhagic fever

Indexed keywords

BRINCIDOFOVIR; CIDOFOVIR; FAVIPIRAVIR; ZMAPP;

ANTIVIRAL THERAPY; ARTICLE; CLINICAL FEATURE; CONTACT EXAMINATION; CONTROLLED CLINICAL TRIAL (TOPIC); DISINFECTION; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EPIDEMIC; EXPERIMENTAL THERAPY; FOREST; GLOVE; GUINEA; HAND WASHING; HEALTH CARE PERSONNEL; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; LABORATORY TEST; N95 RESPIRATOR; NONHUMAN; OCCUPATIONAL HEALTH; PATIENT CARE; PATIENT SAFETY; PROTECTIVE CLOTHING; PROTECTIVE EQUIPMENT; PUBLIC HEALTH SERVICE; TRAVEL; UNITED STATES; VENTILATOR; VIRUS IDENTIFICATION; VIRUS TRANSMISSION; WASTE MANAGEMENT; WORLD HEALTH ORGANIZATION; BIOLOGICAL THERAPY; DISEASE TRANSMISSION; FLUID THERAPY; HEMORRHAGIC FEVER, EBOLA; PATHOLOGY; PREVENTION AND CONTROL; PROCEDURES;

BIOLOGICAL THERAPY; FLUID THERAPY; HEMORRHAGIC FEVER, EBOLA; HUMANS; INFECTION CONTROL; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL;

EID: 84938288707     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2015.05.005     Document Type: Article

References (45)

1. World Health Organization. Ebola Situation Report. 27 May 2015. Available from: http://apps.who.int/iris/bitstream/10665/172637/1/roadmapsitrep-27May15-eng.pdf?ua=1&ua=1. Accessed June 7, 2015.
2. Enserink M. How many Ebola cases are there really? Science Insider 2014. Available from: http://news.sciencemag.org/health/2014/10/how-many-ebola-cases-are-there-really. Accessed November 23, 2014.
3. M.I. Meltzer, C.Y. Atkins, S. Santibanez, B. Knust, B.W. Petersen, E.D. Ervin, and et al. Estimating the future number of cases in the ebola epidemic - Liberia and Sierra Leone, 2014-2015 MMWR Surveill Summ 63 2014 1 14
4. Team WHOER Ebola virus disease in west africa - the first 9 Months of the epidemic and Forward Projections N Engl J Med 371 2014 1481 1495
5. Liddell AM, Davey RT Jr, Mehta AK, et al. Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States. Ann Intern Med 2015 May 12. [Epub ahead of print].
6. Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International study team Bull World Health Organ 56 1978 247 270
7. H. Feldmann, and T.W. Geisbert Ebola haemorrhagic fever Lancet 377 2011 849 862
8. L.L. Rodriguez, A. De Roo, Y. Guimard, S.G. Trappier, A. Sanchez, D. Bressler, and et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995 J Infect Dis 179 Suppl 1 1999 S170 S176
9. R.A. Fowler, T. Fletcher, W.A. Fischer Ii, F. Lamontagne, S. Jacob, D. Brett-Major, and et al. Caring for Critically Ill patients with ebola virus disease: Perspectives from west africa Am J Respir Crit Care Med 193 2014 733 737
10. B. Kreuels, D. Wichmann, P. Emmerich, J. Schmidt-Chanasit, G. De Heer, S. Kluge, and et al. A case of severe Ebola virus infection complicated by gram-negative septicemia N Engl J Med 371 2014 2394 2401
11. G.M. Lyon, A.K. Mehta, J.B. Varkey, K. Brantly, L. Plyler, A.K. McElroy, and et al. Clinical care of two patients with Ebola virus disease in the United States N Engl J Med 371 2014 2402 2409
12. J.S. Schieffelin, J.G. Shaffer, A. Goba, M. Gbakie, S.K. Gire, A. Colubri, and et al. Clinical illness and Outcomes in patients with ebola in Sierra Leone N Engl J Med 371 2014 2092 2100
13. M.A. Bwaka, M.J. Bonnet, P. Calain, R. Colebunders, A. De Roo, Y. Guimard, and et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients J Infect Dis 179 Suppl 1 1999 S1 S7
14. A.S. Khan, F.K. Tshioko, D.L. Heymann, B. Le Guenno, P. Nabeth, B. Kerstiens, and et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit J Infect Dis 179 Suppl 1 1999 S76 S86
15. S. Baize, D. Pannetier, L. Oestereich, T. Rieger, L. Koivogui, N. Magassouba, and et al. Emergence of zaire ebola virus disease in Guinea N Engl J Med 371 2014 1418 1425
16. E.I. Bah, M.-C. Lamah, T. Fletcher, J. Shevin, D. Brett-Major, A. Sall, and et al. Clinical presentation of patients with ebola virus disease in Conakry, Guinea N Engl J Med 372 2015 42 47
17. Centers for Disease Control and Prevention. Evaluating Patients for Possible Ebola Virus Disease: Recommendations for Healthcare Personnel and Health Officials. 2014. Available from: http://emergency.cdc.gov/han/han00371.asp. Accessed October 15, 2014.
18. Centers for Disease Control and Prevention. Case Definition. 2014. Available from: http://www.cdc.gov/vhf/ebola/hcp/case-definition.html. Accessed October 30, 2014.
19. FDA. Emergency Use Authorizations. Medical Device Safety/Emergency Situations 2014. Available from: http://www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm161496.htm. Accessed November 23, 2014.
20. Centers for Disease Control and Prevention. Interim Guidance for Specimen Collection, Transport, Testing, and Submission for Patients with Suspected Infection with Ebola Virus Disease. 2014. Available from: http://www.cdc.gov/vhf/ebola/hcp/interim-guidance-specimen-collection-submission-patients-suspected-infection-ebola.html. Accessed October 30, 2014.
21. Centers for Disease Control and Prevention. Considerations for Discharging Persons Under Investigation (PUI) for Ebola Virus Disease (Ebola). 2014. Available from: http://www.cdc.gov/vhf/ebola/hcp/considerations-discharging-pui.html. Accessed November 25, 2014.
22. Centers for Disease Control and Prevention. Guidance on Personal Protective Equipment To Be Used by Healthcare Workers During Management of Patients with Ebola Virus Disease in U.S. Hospitals, Including Procedures for Putting On (Donning) and Removing (Doffing). 2014. Available from: http://www.cdc.gov/vhf/ebola/hcp/procedures-for-ppe.html. Accessed September 11, 2014.
23. W.A. Fischer Ii, N.A. Hynes, and T.M. Perl Protecting health care workers from ebola: personal protective equipment is critical but is not Enough Ann Intern Med 161 2014 753 754
24. E. Mupere, O.F. Kaducu, and Z. Yoti Ebola haemorrhagic fever among hospitalised children and adolescents in northern Uganda: epidemiologic and clinical observations African Health Sciences 1 2001 60 65
25. L.E. Hensley, S.M. Jones, H. Feldmann, P.B. Jahrling, and T.W. Geisbert Ebola and Marburg viruses: pathogenesis and development of countermeasures Curr Mol Med 5 2005 761 772
26. Y. Guimard, M.A. Bwaka, R. Colebunders, P. Calain, M. Massamba, A. De Roo, and et al. Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995 J Infect Dis 179 Suppl 1 1999 S268 S273
27. P. Roddy, R. Colebunders, B. Jeffs, P.P. Palma, M. Van Herp, and M. Borchert Filovirus hemorrhagic fever outbreak case management: a review of current and future treatment options J Infect Dis 204 Suppl 3 2011 S791 S795
28. D.V. Clark, P.B. Jahrling, and J.V. Lawler Clinical management of filovirus-infected patients Viruses 4 2012 1668 1686
29. X. Qiu, G. Wong, J. Audet, A. Bello, L. Fernando, J.B. Alimonti, and et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp Nature 514 2014 47 53
30. M. McCarthy US signs contract with ZMapp maker to accelerate development of the Ebola drug BMJ 349 2014 g5488
31. T.W. Geisbert, A.C. Lee, M. Robbins, J.B. Geisbert, A.N. Honko, V. Sood, and et al. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study Lancet 375 2010 1896 1905
32. L. Oestereich, A. Ludtke, S. Wurr, T. Rieger, C. Munoz-Fontela, and S. Gunther Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model Antiviral Res 105 2014 17 21
33. World Health Organization. Background Document. Potential Ebola Therapies and Vaccines. 2-14. Available from: http://www.who.int/csr/disease/ebola/ebola-new-interventions-02-sep-2014.pdf?ua=1. Accessed September 29, 2014.
34. World Health Organization. Use of Convaslescent Whole Blood or Plasma Collected from Patients Recovered from Ebola Virus Disease for Transfusion, as an Empirical Treatment during Outbreaks. 2014. Available from: http://apps.who.int/iris/bitstream/10665/135591/1/WHO-HIS-SDS-2014.8-eng.pdf?ua=1. Accessed October 12, 2014.
35. World Health Organization. WHO Blood Regulators Network (BRN); Position Paper on Collection and Use of Convalescent Plasma or Serum as an Element in Filovirus Outbreak Response. 2014. Available from: http://www.who.int/bloodproducts/brn/brn-positionpaperconvplasmafiloviruses-finalweb14august2014.pdf. Accessed October 12, 2014.
36. P.B. Jahrling, T.W. Geisbert, J.B. Geisbert, J.R. Swearengen, M. Bray, N.K. Jaax, and et al. Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections J Infect Dis 179 Suppl 1 1999 S224 S234
37. N.M. Kudoyarova-Zubavichene, N.N. Sergeyev, A.A. Chepurnov, and S.V. Netesov Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections J Infect Dis 179 Suppl 1 1999 S218 S223
38. K. Mupapa, M. Massamba, K. Kibadi, K. Kuvula, A. Bwaka, M. Kipasa, and et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee J Infect Dis 179 Suppl 1 1999 S18 S23
39. O.G. Gene, B.E. Julia, M.R. Vanessa, W.J. Victoria, G.W. Thomas, and H.E. Lisa Drug targets in infections with Ebola and Marburg viruses Infectious Disorders Drug Targets 9 2009 191 200
40. P.B. Jahrling, J.B. Geisbert, J.R. Swearengen, T. Larsen, and T.W. Geisbert Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates J Infect Dis 196 Suppl 2 2007 S400 S403
41. World Health Organization. Interim Infection Prevention and Control Guidance for Care of Patients with Suspected or Confirmed Filovirus Haemorrhagic Fever in Health-Care Settings, with Focus on Ebola. 2014. Available from: http://apps.who.int/iris/bitstream/10665/130596/1/WHO-HIS-SDS-2014.4-eng.pdf?ua=1&ua=1&ua=1. Accessed October 25, 2014.
42. Centers for Disease Control and Prevention. Interim Guidance for Environmental Infection Control in Hospitals for Ebola Virus. 2014. Available from: http://www.cdc.gov/vhf/ebola/hcp/environmental-infection-control-in-hospitals.html. Accessed November 7, 2014.
43. J.L. Sagripanti, A.M. Rom, and L.E. Holland Persistence in darkness of virulent alphaviruses, Ebola virus, and Lassa virus deposited on solid surfaces Arch Virol 155 2010 2035 2039
44. Centers for Disease Control and Prevention. Q&As on Transmission. Ebola Virus Disease 2014. Available from: http://www.cdc.gov/vhf/ebola/transmission/qas.html. Accessed October 31, 2014.
45. Centers for Disease Control and Prevention. Interim U.S. Guidance for Monitoring and Movement of Persons with Potential Ebola Virus Exposure. 2014. Available from: http://www.cdc.gov/vhf/ebola/exposure/monitoring-and-movement-of-persons-with-exposure.html. Accessed November 1, 2014.